Increasing access to medications for opioid use disorder in residential treatment centers
Scaling-up Medication for Opioid Use Disorder in Residential Treatment Settings
This study is looking at ways to make it easier for residential treatment programs to use medications like methadone and buprenorphine to help people with opioid use disorder, especially those at risk of overdose after they leave treatment, so that they can get better support during their recovery.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Rutgers Biomedical and Health Sciences NIH-funded |
| Lab location | 1 site (Newark, UNITED STATES) |
| Project ID | NIH-11061403 on NIH RePORTER |
What this research studies
This research investigates how to improve the use of medications for opioid use disorder (MOUD) like methadone and buprenorphine in residential treatment programs. It aims to identify the factors that can help these programs adopt MOUD more effectively, especially for individuals who are at high risk of overdose after leaving treatment. By analyzing data and implementing new strategies, the research seeks to enhance the support for patients during their recovery journey. The study is particularly focused on Medicaid beneficiaries who are vulnerable to opioid use disorder.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with opioid use disorder who are receiving or have recently completed treatment in residential programs.
Not a fit: Patients who are not struggling with opioid use disorder or those who are not engaged in residential treatment programs may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly reduce the risk of overdose and improve recovery outcomes for individuals with opioid use disorder.
How similar studies have performed: Previous research has shown that increasing access to medications for opioid use disorder can lead to better treatment outcomes, indicating that this approach has potential for success.
Where this research is happening
Newark, UNITED STATES
- Rutgers Biomedical and Health Sciences — Newark, United States (Active)
Researchers
- Principal investigator: Miles, Jennifer — Rutgers Biomedical and Health Sciences
- Study coordinator: Miles, Jennifer
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.